Larimar Therapeutics, Inc. (LRMR) Balance Sheet
As of 2026-06-30 (10-Q), Larimar Therapeutics, Inc. (LRMR) reported total assets of $165.3M, total liabilities of $37.9M and shareholders' equity of $127.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $92.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LRMRLarimar Therapeutics, Inc.Follow LRMR — free
—
Price chart with a free account
- Market cap
- 244.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 11 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 58.1 | 35.6 | 32.4 | 40.8 | 49.3 | 1.0 | 68.1 | 70.1 | 26.8 | 26.7 | 33.2 | 85.4 | 92.7 | |
| Short-term investments | 57.4 | 149.5 | 96.8 | 61.3 | 68.7 | 43.1 | 24.5 | — | 91.6 | 60.0 | 150.2 | 51.4 | 63.6 | |
| Current assets | 117.2 | 188.1 | 130.9 | 104.9 | 121.3 | 4.8 | 98.0 | 72.2 | 120.7 | 90.2 | 195.3 | 142.0 | 160.7 | |
| Total assets | 117.5 | 189.1 | 131.6 | 105.5 | 121.8 | 5.2 | 104.7 | 78.7 | 126.4 | 95.9 | 200.2 | 145.8 | 165.3 | |
| Current liabilities | 6.9 | 16.5 | 9.9 | 7.3 | 13.3 | 5.9 | 9.0 | 8.8 | 10.7 | 9.5 | 24.4 | 64.8 | 34.2 | |
| Long-term debt | 6.2 | 3.5 | 3.2 | 20.0 | 15.2 | 8.5 | — | — | — | — | — | — | — | |
| Total liabilities | 13.1 | 20.0 | 9.9 | 27.3 | 28.5 | 5.9 | 15.0 | 14.3 | 15.5 | 14.2 | 28.4 | 67.8 | 37.9 | |
| Shareholders' equity | 104.4 | 169.1 | 121.7 | 78.2 | 2.9 | -0.7 | 89.7 | 64.4 | 110.9 | 81.7 | 171.8 | 78.1 | 127.4 |
USD millions · SEC XBRL
Larimar Therapeutics, Inc. — questions
- How much cash does Larimar Therapeutics, Inc. have?
- $92.7M in cash and cash equivalents as of 2026-06-30.
- What are Larimar Therapeutics, Inc.'s total assets?
- $165.3M as of 2026-06-30.
- What is Larimar Therapeutics, Inc.'s shareholders' equity?
- $127.4M as of 2026-06-30.
Every figure on this page comes from Larimar Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.